from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1054/-

LFCtreatmentdescriptionclass of inhibitor

-0.517

Amikacinug/mL Amikacintranslation

-0.641

Cap5-10ug/mL Capreomycintranslation

-1.037

Rox10-50 ug/mL Roxithromycintranslation

0.548

SM2-5 ug/mL Streptomycintranslation

0.459

Tet5-10 ug/mL Tetracyclinetranslation

0.477

Rif0.2-5ug/mL Rifampicintranscription

-0.329

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.917

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.613

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.542

CPZ10-50 ug/mL Chlorpromazinerespiration

0.881

Clofazimine10-13 ug/mL Clofaziminerespiration

0.383

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.272

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.666

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.412

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.081

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.922

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.276

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.007

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.253

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.637

KCN5-20 ug/mL Potassium cyaniderespiration

-1.240

NaN30.2-2 mM Sodium aziderespiration

0.751

Nigericin50 uM Nigericinrespiration

-0.542

TRC10-150 ug/mL Triclosanrespiration

-0.179

TRZ10-25 ug/mL Thioridazinerespiration

0.714

Valinomycin0.5-10 uM Valinomycinrespiration

-0.632

ZnSO42 mM ZnSO4respiration

0.468

menadione6-10 ug/mL Menadionerespiration

0.280

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.009

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.322

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.461

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.351

NRP_1Non-replicating persistence stage 1dosRassociated

0.170

Amp0.2mg/mL AmpicillincellWall

0.236

Cephalexin20-100 ug/mL CephalexincellWall

0.621

Cerulenin0.32-5 ug/mL CerulenincellWall

0.612

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.719

EMB10-20 ug/mL EthambutolcellWall

-0.191

Eta12-40 ug/mL EthionamidecellWall

0.219

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.172

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.501

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.019

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.075

BZA0.12 mg/mL BenzamidearomaticAmides

-0.220

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.797

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.105

H2O24 mM hydrogen peroxideDNAdamaging

-0.464

Levo10 ug/mL LevofloxacinDNAdamaging

-0.029

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.674

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.396

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.339

UVUV-irradiationDNAdamaging

-0.130

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.042

Antimycin12.5-50 ug/mL Antimycin A?

-0.250

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.371

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.005

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.507

PA8240.2-2 ug/mL PA-824?

-0.044

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.418

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.213

Verapamil50 uM Verapamil?

-0.252

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.666

methoxatin10-20 ug/mL Methoxatin?